These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20813207)

  • 1. SLE diagnosis and treatment: when early is early.
    Doria A; Zen M; Canova M; Bettio S; Bassi N; Nalotto L; Rampudda M; Ghirardello A; Iaccarino L
    Autoimmun Rev; 2010 Nov; 10(1):55-60. PubMed ID: 20813207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it SLE?
    Maddison PJ
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):167-80. PubMed ID: 12041947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive strategies in systemic lupus erythematosus.
    Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P
    Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
    Riboldi P; Gerosa M; Moroni G; Radice A; Allegri F; Sinico A; Tincani A; Meroni PL
    Autoimmunity; 2005 Feb; 38(1):39-45. PubMed ID: 15804704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome.
    Alba P; Bertolaccini ML; Khamashta MA
    Expert Rev Clin Immunol; 2007 Jul; 3(4):613-22. PubMed ID: 20477165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
    Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
    J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes.
    Pluchinotta FR; Schiavo B; Vittadello F; Martini G; Perilongo G; Zulian F
    Lupus; 2007; 16(8):550-5. PubMed ID: 17711887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus.
    Sinico RA; Bollini B; Sabadini E; Di Toma L; Radice A
    J Nephrol; 2002; 15 Suppl 6():S20-7. PubMed ID: 12515370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
    Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
    Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.